Exercise Testing for Heart Injury Detection After Surgery
(EnhanceMINS Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn whether physicians can associate evidence of myocardial injury after surgery with findings obtained from submaximal cardiopulmonary exercise testing. The main questions are: Is detection of postoperative myocardial injury with submaximal cardiopulmonary exercise testing superior to using usual care? And which submaximal cardiopulmonary exercise testing measure is better? Participants will undergo evaluation with a short submaximal cardiopulmonary exercise test, then undergo surgery. Myocardial injury will be measured on postoperative days 0, 1, 2, and 3 (during and up to 3 days after surgery). These results will analyzed by comparing it to findings from the submaximal cardiopulmonary exercise test. If there is a relationship, this will help anesthesiologists and surgeons assign certain treatments that may reduce the risk of developing myocardial injury after surgery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Submaximal Cardiopulmonary Exercise Testing for detecting heart injury after surgery?
Cardiopulmonary exercise testing is shown to be effective in assessing heart function and predicting outcomes in surgical patients by measuring how well the heart and lungs work together during exercise. It helps identify patients at higher risk of complications after surgery, which can guide better care and improve recovery.12345
Is cardiopulmonary exercise testing safe for humans?
Cardiopulmonary exercise testing (CPET) is generally considered safe when proper precautions and safety standards are followed, as it is a noninvasive tool used to assess heart and lung function before surgery. It is used to predict risks and outcomes in various surgeries, and while it helps in identifying potential complications, the testing itself is not associated with significant safety concerns.678910
How does the treatment Submaximal Cardiopulmonary Exercise Testing differ from other treatments for detecting heart injury after surgery?
Submaximal Cardiopulmonary Exercise Testing is unique because it uses exercise to assess heart and lung function, specifically measuring the anaerobic threshold (the point at which the body starts to use more energy from anaerobic sources). This approach helps detect heart issues that might not be visible through other tests, making it a valuable tool for identifying cardiac risk in patients who have undergone surgery.111121314
Research Team
Zyad J Carr, M.D.
Principal Investigator
Yale University
Eligibility Criteria
This trial is for individuals undergoing non-cardiac surgery who will be assessed for myocardial injury, which is heart damage that can occur after surgery. Participants must be able to perform a submaximal cardiopulmonary exercise test before their operation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo submaximal cardiopulmonary exercise testing to assess preoperative risk
Surgery and Immediate Postoperative Monitoring
Participants undergo surgery and are monitored for myocardial injury using high-sensitivity troponin measurements on operative day 0 and postoperative days 1, 2, and 3
Follow-up
Participants are monitored for major adverse cardiovascular events and other outcomes up to 30 days post-surgery
Extended Follow-up
Participants are monitored for readmission and length of stay up to 60 days post-surgery
Treatment Details
Interventions
- Submaximal Cardiopulmonary Exercise Testing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor